A new study has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure or prior heart attacks. The findings will help doctors and patients weigh the benefits and risks of the drugs. Androgen deprivation therapy (ADT), which reduces levels of male hormones in the body to
